Decibel Therapeutics, Inc. DBTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

There have been 50 recent insider transactions recorded for Decibel Therapeutics, Inc. (DBTX), including 23 buys and 20 sells. Total insider buying was valued at $3.3M and total insider selling at $6.91M.

Notable insiders with recent activity include Mclaughlin Kevin F, Reid Laurence, Kapusta Matthew C. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — DBTX

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2023-09-25	Mclaughlin Kevin F	Director	Return of Shares	5,000	$4.78	$23.9K	-
2023-09-25	Reid Laurence	See Remarks	Return of Shares	1,072,539	$4.40	$4.72M	-
2023-09-25	Kapusta Matthew C	Director	Return of Shares	10,000	$3.34	$33.4K	-
2023-09-25	Finger Alison Cecily	Director	Return of Shares	20,000	$6.20	$124K	-
2023-09-25	Carson William H.	Director	Return of Shares	20,000	$8.42	$168.4K	-
2023-09-25	Trask Anna	Chief People Officer	Return of Shares	137,302	$4.40	$604.13K	-
2023-09-25	Lee John Jui-jen	Chief Development Officer	Return of Shares	232,003	$4.40	$1.02M	-
2023-09-25	Nochur Sara	Director	Return of Shares	20,000	$6.20	$124K	-
2023-06-13	Mclaughlin Kevin F	Director	RSU Award	5,000	$4.78	$23.9K	5,000
2023-06-13	Finger Alison Cecily	Director	RSU Award	5,000	$4.78	$23.9K	5,000
2023-06-13	Carson William H.	Director	RSU Award	5,000	$4.78	$23.9K	5,000
2023-06-13	Nochur Sara	Director	RSU Award	5,000	$4.78	$23.9K	5,000
2023-03-19	Kapusta Matthew C	Director	Unknown	-	-	-	-
2023-03-19	Kapusta Matthew C	Director	RSU Award	10,000	$3.34	$33.4K	10,000
2023-03-16	Reid Laurence	See Remarks	RSU Award	72,000	$3.73	$268.56K	72,000
2023-01-26	Trask Anna	Chief People Officer	RSU Award	45,000	-	-	45,000
2023-01-26	Lee John Jui-jen	Chief Development Officer	RSU Award	45,000	-	-	45,000
2022-10-10	Mclaughlin Kevin F	Director	Unknown	-	-	-	-
2022-10-10	Mclaughlin Kevin F	Director	RSU Award	20,000	-	-	20,000
2022-10-07	Murphy James B	Officer	Unknown	-	-	-	-
2022-06-17	Thompson Peter A.	10 Percent Owner	RSU Award	10,000	$2.30	$23K	10,000
2022-06-17	Exter Neil	10 Percent Owner	RSU Award	10,000	$2.30	$23K	10,000
2022-06-17	Finger Alison Cecily	Director	RSU Award	10,000	$2.30	$23K	10,000
2022-06-17	Carson William H.	Director	RSU Award	10,000	$2.30	$23K	10,000
2022-06-17	Nochur Sara	Director	RSU Award	10,000	-	-	10,000
2022-02-25	Reid Laurence	See Remarks	RSU Award	187,500	$3.50	$656.25K	187,500
2022-02-25	Trask Anna	See Remarks	RSU Award	52,500	$3.50	$183.75K	52,500
2022-02-25	Leiderman Elisabeth	Chief Financial Officer	RSU Award	52,500	$3.50	$183.75K	52,500
2022-02-25	Lee John Jui-jen	Chief Development Officer	RSU Award	52,500	$3.50	$183.75K	52,500
2022-01-03	Trask Anna	See Remarks	Informative Sell	377	$5.03	$1.9K	1,864
2021-12-03	Finger Alison Cecily	Director	Unknown	-	-	-	-
2021-12-03	Finger Alison Cecily	Director	RSU Award	20,000	$6.20	$124K	20,000
2021-12-03	Nochur Sara	Director	Unknown	-	-	-	-
2021-12-03	Nochur Sara	Director	RSU Award	20,000	$6.20	$124K	20,000
2021-12-02	Trask Anna	See Remarks	Informative Sell	378	$6.34	$2.39K	2,242
2021-11-03	Trask Anna	See Remarks	Informative Sell	378	$8.34	$3.15K	7,533
2021-11-02	Trask Anna	See Remarks	Informative Sell	4,913	$8.31	$40.83K	7,911
2021-10-14	Trask Anna	See Remarks	Informative Sell	5,364	$7.55	$40.48K	12,824
2021-09-15	Reid Laurence	President and Chief Executive	Informative Buy	10,000	$7.64	$76.4K	25,849
2021-08-16	Hu Cynthia W.	Officer	Unknown	-	-	-	-
2021-08-16	Hu Cynthia W.	General Counsel	RSU Award	150,000	$7.37	$1.11M	150,000
2021-06-02	Carson William H.	Director	Unknown	-	-	-	-
2021-06-02	Carson William H.	Director	RSU Award	20,000	$8.42	$168.4K	20,000
2021-02-17	Gv 2016 Gp, L.l.c.	10 Percent Owner	Conversion (Sell)	5,000,000	-	-	-
2021-02-17	Gv 2017 Gp, L.l.c.	10 Percent Owner	Conversion (Sell)	6,250,000	-	-	-
2021-02-17	Gv 2019 Gp, L.l.c.	10 Percent Owner	Conversion (Sell)	4,344,048	-	-	-
2021-02-17	Regeneron Pharmaceuticals, Inc.	10 Percent Owner	Conversion (Sell)	14,000,000	-	-	-
2021-02-17	Longevity Fund 2 Lp	10 Percent Owner	Conversion (Sell)	79,143	-	-	-
2021-02-17	Orbimed Advisors Llc	10 Percent Owner	Conversion (Sell)	1,158,412	-	-	-
2021-02-17	Glaxosmithkline Plc	Director	Conversion (Sell)	1,737,619	-	-	-

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry